Patient Enrollment Equipment
-
Manufactured by Biocartis NVbased in BELGIUM
The fully automated Idylla ctKRAS Mutation Test is minimally invasive, fast and easy to perform and can be used as complement to tissue testing to determine the RAS mutation status at diagnosis. IdyllaTM ctKRAS covers 21 KRAS mutations in exons 2,3 and 4 and showed an high concordance to NGS of 96% using plasma samples from 198 mCRC ...
-
Manufactured by Tasso, Inc.based in USA
The Tasso-M20 device delivers whole dried blood samples from the patient to the lab. It can be used for PK (pharmacokinetic) monitoring in patients enrolled in clinical trials. Subjects can successfully collect volumetrically precise samples regardless of access to trial sites. The Tasso-M20 is CE marked and FDA ...
-
Manufactured by Veracyte, Inc.based in USA
LymphMark (Lymphoma) – We are developing this lymphoma subtyping test as a companion diagnostic for Acerta Pharma and AstraZeneca’s acalabrutinib (Calquence®). In April 2021, we announced that the first patient has been enrolled and randomized in Acerta Pharma’s Phase 3 ESCALADE trial, which uses the investigational ...
-
Manufactured by CytomX Therapeutics, Inc.based in USA
Bristol Myers Squibb is enrolling patients in the dose escalation phase of a Phase 1/2a clinical trial (NCT03994601) of a second anti-CTLA-4 Probody, BMS-986288, based on a modified version of Yervoy® (ipilimumab), to evaluate a CTLA-4-directed Probody therapeutic alone or in combination with Opdivo® (nivolumab) in patients with ...
-
based in USA
ability to reversibly bind XPO1 may offer the possibility to mitigate side effects and help optimize the therapeutic index. A multicenter Phase 1 dose escalation trial of single agent SL-801 is currently enrolling patients with advanced solid ...
-
Manufactured by AOBiome Therapeutic, LLCbased in USA
We have completed six Phase 2 clinical programs and multiple pre-clinical programs. Over 1,000 patients have been enrolled in our clinical trials since 2016. All of those patients except for 28 in our open label pediatric study have been enrolled in randomized double-blind placebo controlled clinical trials evaluating both ...
-
Manufactured by SystImmune Inc.based in USA
, and secondarily, through a wt FC receptor mediating innate immune effector functions toward the cancer cells. SI-B001 is currently being evaluated as a single agent in clinical trials enrolling patients with a variety of solid tumor ...
-
Manufactured by SystImmune Inc.based in USA
upon treatment with PD-1 and CTLA-4 blocking antibodies, restoring their anti-tumor activity. SI-B003 is currently being evaluated as a single agent in clinical trials enrolling patients with a variety of solid tumor ...
-
Manufactured by Moebius Medical Ltd.based in ISRAEL
and lubricating properties, which work to reduce joint friction and wear of cartilage, and a first-in-human study has demonstrated MM-II’s tolerability and ability to reduce knee pain in OA patients. The clinical development of MM-II is continuing in collaboration with Sun Pharmaceuticals, and we are currently enrolling patients in a large ...
-
Manufactured by Suvodabased in USA
Get all the benefits of trial supply chain management, even when patient randomization is not ...
-
Manufactured by Longenesisbased in LATVIA
Collect Real World Data and patient outcomes; Longenesis.Engage is a digital patient engagement platform that enables the benefits of digital approach to patient engagement and research execution. Conduct multiple research projects, funnel patient cohorts for upcoming studies, follow-up and re-engage the participants, and manage ...
-
by Abivaxbased in FRANCE
ABX464 is an oral, first-in-class, small molecule that has demonstrated safety and profound anti-inflammatory activity in the completed Phase 2a and Phase 2b induction studies as well as in ongoing long-term maintenance studies in patients with moderate-to-severe ulcerative colitis (UC).Due to the clinical similarities of Crohn’s disease ...
-
Manufactured by SystImmune Inc.based in USA
Built on the foundation of Specificity Enhanced Bi-specific Antibody (SEBA) molecules the SEBA-ADC have an advanced mechanism of action. This advanced functional class is referred to as Heterogeneity overcoming - Immunogenic death inducing - Resistance antagonizing - Enhanced Specificity (HIRE) molecules that target cancer cells. While HIRE molecules provide cancer cells specific targeting, and ...
-
Manufactured by atHeart Medicalbased in SWITZERLAND
Defects vary in size. Some may close on their own early in life, while others require an intervention. Today, the vast majority are performed through minimally invasive catheter-based interventions. They consist in implanting an atrial septal occluder through a transcatheter procedure to close the defect. Current ASD occluder devices have dense metal frames that permanently clamp the septum. The ...
-
Manufactured by Nkarta, Inc.based in USA
OX40 costimulatory domain, CD3ζ signaling moiety, membrane bound ...
-
based in USA
Our DecisionDx-CMSeq is a 3-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to cutaneous melanoma in melanoma tumor tissue. The test includes hotspot mutations in the genes BRAF, NRAS and ...
-
Manufactured by Lineage Cell Therapeutics, Inc.based in USA
On December 20, 2021, Lineage announced that it has entered into an exclusive worldwide collaboration and license agreement with Roche and Genentech, a member of the Roche Group, for the development and commercialization of OpRegen for the treatment of ocular disorders, including advanced dry age-related macular degeneration (dry AMD) with geographic atrophy (GA) in a transaction worth up to $670 ...
-
Manufactured by Sense Neuro Diagnosticsbased in USA
Sense is developing non-invasive brain scanners that enable faster detection and triage, and continuous monitoring of brain injury, to improve patient ...
-
Manufactured by SystImmune Inc.based in USA
Antibody Drug Conjugates (ADC) molecules utilize specific antibodies to deliver therapeutic small molecules specifically to cancer cells. ADC are created in cooperation with Bai-Li Pharmaceutical’s R&D Center of Excellence and enable the development of sophisticated chemistries that give this class of drugs their therapeutic payload. This advanced functional class is referred to ...
-
Manufactured by BioXcel Therapeutics, Inc.based in USA
BXCL701 (talabostat) is an investigational, oral small molecule inhibitor of dipeptidyl peptidases (DPP)—primarily DPP 8/9 and DPP 4—which triggers inflammasome to alert and prime immune cells, leading to induction of IL-18 and IL-1ß, bridging innate & adaptive immunity. BXCL701 is currently being developed for the treatment of aggressive forms of prostate cancer and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you